Authors: Atencio, IA Avanzini, JB Johnson, D Neuteboom, S Vaillancourt, MT Nielsen, LL Hajian, G Sutjipto, S Sugarman, BJ Philopena, J McAllister, DL Beltran, JC Nodelman, M Ramachandra, M Wills, KN

Citation: Ia. Atencio et al., Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment, MOL THER, 4(1), 2001, pp. 5-12

Authors: Ahmed, CMI Wills, KN Sugarman, BJ Johnson, DE Ramachandra, M Nagabhushan, TL Howe, JA

Citation: Cmi. Ahmed et al., Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice, J INTERF CY, 21(6), 2001, pp. 399-408

Authors: Ahmed, CMI Johnson, DE Demers, GW Engler, H Howe, JA Wills, KN Wen, SF Shinoda, J Beltran, J Nodelman, M Machemer, T Maneval, DC Nagabhushan, TL Sugarman, BJ

Citation: Cmi. Ahmed et al., Interferon alpha 2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers, CANC GENE T, 8(10), 2001, pp. 788-795

Authors: Wills, KN Atencio, IA Avanzini, JB Neuteboom, S Phelan, A Philopena, J Sutjipto, S Vaillancourt, MT Wen, VF Ralston, RO Johnson, DE

Citation: Kn. Wills et al., Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus, J VIROLOGY, 75(18), 2001, pp. 8733-8741

Authors: Ahmed, CMI Sugarman, BJ Johnson, DE Bookstein, RE Saha, DP Nagabhushan, TL Wills, KN

Citation: Cmi. Ahmed et al., In vivo tumor suppression by adenovirus-mediated interferon alpha 2b gene delivery, HUM GENE TH, 10(1), 1999, pp. 77-84